CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Top Cited Papers
- 1 July 2009
- Vol. 138 (2), 286-299
- https://doi.org/10.1016/j.cell.2009.05.045
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid PhagocytosisCell, 2009
- Dysregulated gene expression networks in human acute myelogenous leukemia stem cellsProceedings of the National Academy of Sciences, 2009
- An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemiaBlood, 2008
- Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord BloodCell Stem Cell, 2007
- CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemiaProceedings of the National Academy of Sciences, 2007
- Role for CD47-SIRPα signaling in xenograft rejection by macrophagesProceedings of the National Academy of Sciences, 2007
- Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?Blood, 2006
- A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cellsBiochemical and Biophysical Research Communications, 2004
- Acute Myeloid LeukemiaNew England Journal of Medicine, 1999
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997